If we really want to tackle the fact that Texas has one of the highest kill rates in animal shelters, then we have to make it even a little bit easier for people to own dogs and cats in our state.” ...

COUNTY NEWS RELEASE The Risk of Rabies The rabies virus is usually transmitted through a bite or scratches. Animals most ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

A pet camera lets you monitor your cat or dog 24/7—and some even let you give them treats! These are the best pet cameras we’ve tested, plus some of our favorite security cameras that work as ...

Cloud storage and file-sharing services play a crucial role in businesses of all sizes. Our top, tested picks can help your company cut costs, streamline workflows, and strengthen data security.

Winter's arrival often brings the challenge of managing snow and ice accumulation around our homes. While commercial de-icing ...

Adding wellness coverage to your pet insurance plan can pay for routine costs like annual checkups, vaccinations, and flea and tick treatments, as well as one-time expenses like microchipping and ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...